# MONTANI BIOTECHNOLOGIES, INC: Optimization of mRNA genetic adjuvant for immunotherapy

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | MONTANI BIOTECHNOLOGIES, INC |
| Location | MORGANTOWN, WV |
| Project | Optimization of mRNA genetic adjuvant for immunotherapy |
| Project number | 1R43CA310296-01 |
| Mechanism | R43 |
| Institute | National Cancer Institute |
| Award | $312,589 |
| Awarded | 2026-09-09 |
| Project period | 2026-09-09 to 2027-02-28 |
| UEI | ZD8TZNSU7HD8 |

## Why this score
- Award of $312,589.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11315302). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.